Kenta Watanabe

Dr. Kenta Watanabe

Akita University, Akita, Japan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2026 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
KWKenta Watanabe
Kenta Watanabe
SFSho Fukuda
Sho Fukuda
DKDai Kubota
Dai Kubota
NYNobutake Yamamichi
Nobutake Yamamichi
YTYu Takahashi
Yu Takahashi
KIKatsunori Iijima
Katsunori Iijima
Background and Aim: In Japan, gastric cancer (GC) and esophageal squamous cell carcinoma (ESCC) account for nearly all fatal upper gastrointestinal malignancies. A unified model that simultaneously predicts the incidence of these two cancers could help optimize endoscopic screening and postindex surveillance strategies. Methods: We conducted a retrospective multicenter cohort study of 33 422 individuals who underwent screening esophagogastroduodenoscopy (EGD) at 17 health check‐up institutions across Japan. Clinical and endoscopic data from the index EGD were used to develop a 5‐year risk prediction model for GC or ESCC. Significant predictors were identified using Cox regression, and a scoring system (J‐GESS score) was constructed by scaling β coefficients. Model performance was evaluated using the 5‐year inverse probability of censoring weighted (IPCW) Brier score, calibration, and c indices. Internal validation used bootstrap resampling (500 iterations) to obtain optimism‐corrected estimates. Decision curve analysis (DCA) assessed clinical utility at 5 years. Results: At 5 years, the IPCW‐estimated cumulative incidence of GC or ESCC was 0.84% (234 events). Independent predictors included older age, male sex, ever smoking, and endoscopic gastric mucosal atrophy. The model showed good calibration at 5 years (calibration‐in‐the‐large 0.005; slope 1.055; identical after optimism correction) and robust discrimination (Harrell's c index 0.81; Uno's 5‐year c index 0.81). DCA demonstrated positive net benefit across clinically relevant thresholds. Conclusion: Using routinely collected health check‐up data, we developed a unified, practical, and internally validated 5‐year prediction model for GC and ESCC. The J‐GESS score enables effective risk stratification and may inform postindex endoscopic surveillance and screening interval optimization in Japan.

15 March 2023 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
YSYohei Saruta
Yohei Saruta
KWKenta Watanabe
Kenta Watanabe
TTTsuyotoshi Tsuji
Tsuyotoshi Tsuji
YTYasutaka Takahashi
Yasutaka Takahashi
HMHisanori Matsuzawa
Hisanori Matsuzawa
KIKatsunori Iijima
Katsunori Iijima

26 August 2025 in Digestive Endoscopy
Verified
Journal Article
Closed access
KWKenta Watanabe
Kenta Watanabe
SFSho Fukuda
Sho Fukuda
DKDai Kubota
Dai Kubota
NYNobutake Yamamichi
Nobutake Yamamichi
YTYu Takahashi
Yu Takahashi
KIKatsunori Iijima
Katsunori Iijima

14 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
YTYasutaka Takahashi
Yasutaka Takahashi
YSYosuke Shimodaira
Yosuke Shimodaira
TMTamotsu Matsuhashi
Tamotsu Matsuhashi
TTTsuyotoshi Tsuji
Tsuyotoshi Tsuji
SFSho Fukuda
Sho Fukuda
KIKatsunori Iijima
Katsunori Iijima
Acute hemorrhagic rectal ulcer (AHRU) is a relatively rare disease that can lead to massive hematochezia. Although AHRU is a potentially life-threatening disease, its characteristics and clinical course are not fully understood. In this study, the clinical features were compared between AHRU and lower gastrointestinal bleeding (LGIB) from other causes (non-AHRU). Then, risk factors for all-cause in-hospital mortality in patients with AHRU were identified. A total of 387 consecutive adult patients with LGIB who were managed at two tertiary academic hospitals in Akita prefecture in Japan were retrospectively enrolled. Subjects were divided into AHRU and non-AHRU groups according to the source of bleeding. Regression analyses were used to investigate significant associations, and the results were expressed as odds ratios (ORs) and 95% confidence intervals (CIs). AHRU was found as the bleeding source in 72 (18.6%) of the patients. In comparison to non-AHRU, having AHRU was significantly associated with in-hospital onset, age > 65 years, and systolic blood pressure < 90 mmHg. The AHRU group had a significantly higher in-hospital mortality rate in comparison to the non-AHRU group (18.0% vs. 8.3, p = 0.02), and hypoalbuminemia (<2.5 g/dL) was significantly associated with in-hospital mortality in the AHRU group (OR, 4.04; 95%CI, 1.11–14.9; p = 0.03). AHRU accounts for a substantial portion (18.6%) of LGIB in our area, where the aging rate is the highest in Japan. Since AHRU is a potentially life-threatening disease that requires urgent identification and management, further studies to identify robust risk factors associated with serious clinical outcomes are required.

19 August 2024 in Esophagus
Verified
Journal Article
Closed access
PDF file
SKSo Kodama
So Kodama
KWKenta Watanabe
Kenta Watanabe
YSYosuke Shimodaira
Yosuke Shimodaira
SFSho Fukuda
Sho Fukuda
TYTatsuki Yoshida
Tatsuki Yoshida
KIKatsunori Iijima
Katsunori Iijima

30 November 2025 in Digestive Endoscopy
Verified
Journal Article
Closed access
NINorihisa Ishimura
Norihisa Ishimura
NMNobuyuki Matsuhashi
Nobuyuki Matsuhashi
JFJunko Fujisaki
Junko Fujisaki
TETakao Endo
Takao Endo
TKTomoyuki Koike
Tomoyuki Koike
KIKatsunori Iijima
Katsunori Iijima